28 results
8-K
CPHI
China Pharma Holdings Inc.
21 Dec 23
Entry into a Material Definitive Agreement
4:05pm
patent of a drug combination for the treatment of chronic obstructive pulmonary disease (the “Invention Patent”). Pursuant to the Agreement
CORRESP
CPHI
China Pharma Holdings Inc.
8 Sep 23
Correspondence with SEC
12:00am
. These include drugs that treat chronic diseases prevalent in China, such as geriatric diseases, cancers, and nutritional products.
In addition, as another … ; sinusitis, tympanitis, acute and chronic bronchitis caused by acute bacterial infection, Mycoplasma pneumonia and Chlamydia pneumoniae; urethritis